Figure 5 | Scientific Reports

Figure 5

From: Quantifying Tip60 (Kat5) stratifies breast cancer

Figure 5

Key breast cancer clinicopathological variables associated with TMA Tip60 staining patterns. (A) Percent of cytoplasmic only Tip60 staining, by cancer site. (B) Nuclear Tip60 staining positivity by type. Ductal Carcinoma In Situ considered non-invasive/pre-invasive. (C) Nuclear Tip60 staining positivity by indicated tumour grade.

Back to article page